Already a Bloomberg.com user?
Sign in with the same account.
Don't have an account?
Help! I can't access my account.
March 27 (Bloomberg) -- Biogen Idec, the maker of multiple sclerosis drugs Avonex and Tysabri, won U.S. approvalfor its first pill for the disease, Tecfidera. Adam Johnson reports on Bloomberg Television's "Street Smart." (Source: Bloomberg)
On Air Now
C-Suite with Jeffrey Hayzlett
Max 250 characters
©2013 Bloomberg L.P. All Rights Reserved. Made in NYC